In this special episode, High-Rise host Cy Scott is on the road exploring parts of the cannabis industry in Europe. He got the chance to have a discussion with two of the managing partners of Óskare Capital, a cannabis investment firm based in Paris France. Alexandre Ouimet-Storrs, a chemical engineer and venture capitalist, and John Rogers, a clinical neurologist, share the story of how treating epilepsy was the basis for Óskare’s formulation and discuss the work they are doing across Europe today. We get an enlightening perspective on how endocannabinoid research, industry regulation, and investment opportunities are pursued from country to country. European cannabis startups and medical/therapeutic research companies seem to be developing the industry in stark contrast to how US cannabis businesses have been doing it — fascinating to see how this world wide industry is shaping up. Please remember to download and share this special episode of the High-Rise!